Abstract-Mass spectrometry (MS) is an important tool for studying non-ribosomal peptide, polyketide, and fatty acid biosynthesis. Here we describe a new approach using multi-stage tandem MS on a common ion trap instrument to obtain high-resolution measurements of the masses of substrates and intermediates bound to phosphopantetheinylated (holo) carrier proteins. In particular, we report the chemical formulas of 12 diagnostic MS 3 fragments of the phosphopantetheine moiety ejected from holo carrier proteins during MS 2 . We demonstrate our method by observing the formation of holo-AcpC, a putative acyl carrier protein from Streptococcus agalactiae. Published by Elsevier Ltd.
The biosynthesis of polyketide synthase (PKS) and nonribosomal peptide synthetase (NRPS) natural products, including the well-established therapeutic agents penicillin, vancomycin, and rapamycin, requires post-translational modification of carrier proteins by addition of a 4 0 -phosphopantetheine (PPant) arm. The sulfur at the free end of this moiety forms a thioester bond with substrates and intermediates at each step of the biosynthetic process. Because these substrates and intermediates increase the overall mass of the associated carrier proteins, the latter are ideal targets for 'top-down' characterization of PKS and NRPS pathways by mass spectrometry (MS). 1 A top-down approach was recently shown to facilitate the study of phosphopantetheinyl-tethered substrates. 2 Thermal activation by infrared multiphoton dissociation (IRMPD) or collision-induced dissociation (CID) causes the holo form of acyl and peptidyl carrier proteins, which are found in PKS and NRPS pathways, respectively, to consistently 'eject' their PPant arm, preserving the thioester linkage to the substrate (Fig. 1a) . This 'PPant ejection assay' allows the mass of substrates loaded onto carrier proteins to be readily deduced from the mass of the corresponding PPant fragments.
3 Specifically, when no substrate is linked to the PPant arm, the fragment ejected from the carrier protein has chemical formula C 11 H 21 N 2 O 3 S + , giving an MS 2 peak at m/z 261.1267. When an acyl or peptidyl substrate is bound to the PPant arm, the PPant peak in the MS 2 spectrum is shifted by an amount equal to the mass of the substrate less a water molecule. 4 The PPant ejection assay can greatly facilitate the characterization of NRPS and PKS systems by mass spectrometry, but demands instruments capable of both high sensitivity and high accuracy. Indeed, PPant ejection was originally observed on a custom-built Fourier transform ion cyclotron resonance (FTICR)-MS that utilized an accumulation octopole to collect ions before transmission to the FTICR mass analyzer. 5 However, commercial FTICR-MS instruments may not produce peaks sufficiently intense for reliable detection of the ejected PPant species. Conversely, ion trap mass spectrometers, while typically more sensitive and capable of higher scan rates than FTICR instruments, do not always provide sufficient accuracy and signalto-noise ratio to confirm the elemental composition of the PPant ejection peak.
These limitations became evident when we applied the PPant ejection assay on a Finnigan LTQ MS to characterize AcpC (Accession No. NP_735098), a putative 12.4-kDa acyl carrier protein encoded by the fourth open-reading frame in the cyl gene cluster of the bacterial pathogen Streptococcus agalactiae, or group B Streptococcus (GBS). 6 The cyl gene cluster of GBS is involved in the production of the b-hemolytic/cytolytic activity that contributes to the virulence of GBS, a major cause of infant mortality in industrialized countries. Remarkably, the structure of the final molecule produced by the cyl gene cluster is still unknown. 7 Because disruption of the acpC gene by transposon mutagenesis has suggested that AcpC is essential for hemolytic phenotype of GBS, 6 we decided to study this protein. To begin our investigation, we expressed an AcpC-His 6 fusion construct in Escherichia coli and enriched the protein by Ni-NTA affinity chromatography. 16 The resulting sample was subjected to nano-electrospray ionization (ESI) and collision-induced dissociation (CID) of the predicted 16+ charge state (m/z 796) in the linear ion trap, yielding a clearly discernible peak at m/z 261.2 (Fig. 1b) . 17 This peak matches the mass of the MS 2 PPant fragment, suggesting that AcpC is a carrier protein and that AcpC can be phosphopantetheinylated by a PPant transferase (PPTase) naturally occurring in E. coli. However, the peak at m/z 261.2 was much weaker than the other peaks present in the MS 2 spectrum and the accuracy of the ion trap mass analyzer was not sufficient for unequivocal assignment of this peak to the PPant fragment.
We therefore investigated whether subjecting the putative MS 2 PPant fragment of holo-AcpC to another round of fragmentation would yield a more informative mass spectrum. Indeed, we observed a rich pattern of MS 3 peaks that appeared to be uniquely associated with the ejected PPant arm (Fig. 1c) . 18 We reasoned that this fragmentation pattern could be generally exploited as a diagnostic tool to detect the presence of carrier proteins bearing the PPant arm and to determine the mass of any PPant-linked species. Hence, we developed an alternative top-down method for the unambiguous characterization of substrates and intermediates bound to carrier proteins of PKS and NRPS biosynthetic pathways.
The likely molecular formulas for 12 of the observed MS 3 PPant ions (Fig. 1c) peaks resulting from fragmentation of the PPant fragment itself, can all be calculated a priori from the theoretical masses listed in Figure 1c and from the mass of the given substrate. 8 To evaluate our approach and to optimize the instrumental settings, CouN5, a 11.8-kDa peptidyl carrier protein from the coumermycin A 1 NRPS biosynthetic pathway of Streptomyces rishiriensis DSM 40489, 9 was used as a model system, because CouN5 is known to produce an abundant MS 2 PPant fragment ion. (Fig. 2a) . 20 These values agree with those observed for AcpC (Fig. 1c) . We verified the expected substrate-dependent mass shifts by performing MS 3 experiments on CouN5 loaded with acetamide by Sfp, and by observing the expected +57-Da shift of the nine thiol-containing fragments (Fig. 2b) . 21 Since a total of 12 MS 3 PPant fragments must be present at m/z values predictable from the mass of the PPant-linked substrate, this mass can be determined with high confidence.
We applied our approach to confirm the phosphopantetheinylation of the acyl carrier protein AcpC after incubation with CoA in the presence or absence of Sfp. In both cases, analysis of the reaction products by nanocapillary LC-ESI and linear ion trap MS revealed charge state distributions consistent with the presence of both holo-and apo-AcpC. However, the presence of Sfp correlated with an increased proportion of holo-AcpC relative to apo-AcpC (Fig. 3a) . CID on the 16+ charge state (m/z 796) of Sfp-treated AcpC, followed by CID with precursor at m/z 261, yielded peaks at m/z 132. (Fig. 3b) , which agree with the pattern of MS 3 ions observed for holo-CouN5 (Fig. 1c) . 22 These results indicate that AcpC was phosphopantetheinylated by Sfp and, to a lesser extent, by an endogenous PPTase of E. coli. One such protein is the 14.1-kDa protein AcpS (Accession No. P24224).
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To determine whether AcpS can phosphopantetheinylate AcpC, we incubated the latter with a BODIPY Figure 2 . Confirming the diagnostic potential of the MS 3 PPant fragments. (a) The MS 3 spectrum of holo-CouN5, with precursors at the 16+ charge state and at the PPant fragment, includes the same 12 peaks observed for holo-AcpC (Fig. 1c) . (b) The MS 3 spectrum of acetamide-S-CouN5, with precursors at the 15+ charge state and at the PPant fragment, shows that nine of the diagnostic peaks are shifted by the mass of the linked substrate (57 Da). reaction products gave fluorescent bands consistent with the molecular weight of AcpC (11.4 kDa), indicating that both Sfp and AcpS can phosphopantetheinylate AcpC (Fig. 4) . 23 Our investigations to date show that ion trap mass spectrometers capable of MS 3 experiments can be used to recognize phosphopantetheinylated carrier proteins of PKS and NRPS pathways and to determine the masses of substrates bound to the holo form of such proteins. The results from our first application of the proposed method indicate that AcpC can be phosphopantetheinylated by two PPTases of rather different substrate specificity. Since expression of AcpC is required for production of hemolytic activity in GBS, 6 our results suggest that formation of holo-AcpC may also be necessary. We propose that this post-translational modification may be accomplished by CylK (Accession No. NP_735106), another product of the cyl gene cluster with very low homology to Sfp and CesP, the PPTase of Bacillus cereus. 13 Interestingly, in-frame deletion of cylK abolishes most, but not all, of the hemolytic activity of GBS.
14 Since we have shown that E. coli AcpS can phosphopantetheinylate AcpC, the residual hemolytic activity of the cylK deletion mutants may be due to phosphopantetheinylation of AcpC by a 'borrowed' PPTase, such as the 4 0 -phosphopantetheinyl transferase of S. agalactiae NEM316 (Accession No. NP_736164), a protein with 50% similarity to AcpS of E. coli, and therefore likely involved in fatty acid biosynthesis.
In conclusion, our top-down approach based on multiple stages of tandem MS has the potential to facilitate the study of NRPS and PKS systems with low-resolution ion trap mass spectrometers. Possible applications of this method include the routine characterization of orphan gene clusters, 15 the implementation of substrate screens, and the identification of phosphopantetheinylated proteins in a proteomic setting on LC time scales. This method may benefit other groups having access to affordable ion trap instruments but not to the costly FTICR-MS instruments currently used for top-down characterization of NRPS and PKS pathways. 14. Forquin, M. 
